Brookings Workshop Explores Cultural Changes Needed To Drive mHealth
This article was originally published in The Gray Sheet
Physicians and patients may need to become more comfortable with giving up some privacy in exchange for achieving better clinical outcomes, speakers suggested at a Brookings Institution workshop.
You may also be interested in...
The Senate user fee reauthorization and FDA reform bill, formally introduced May 15, includes several new provisions, including a moratorium on FDA issuing final guidance on mobile medical apps. The bill should see action on the Senate floor this week.
Sandoz has heralded a “new era as a standalone global leader and European champion in generic and biosimilar medicines” after completing its long journey towards independence by separating from former parent company Novartis.
The former principal deputy commissioner outlined what she sees as the future data requirements for real world evidence and why cell and gene therapy will lead the way.